Cargando…
What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective
Given China’s relatively weak innovative and regulatory capacity compared with developed countries, China’s progress on COVID-19 vaccines is especially impressive. We summarize three key lessons from China’s experience with COVID-19 vaccine R&D: (i) set strategic vaccine R&D goals and achiev...
Autores principales: | Hu, Yinglian, Chen, Simiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989390/ https://www.ncbi.nlm.nih.gov/pubmed/33635318 http://dx.doi.org/10.1093/jtm/taab026 |
Ejemplares similares
-
The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?
por: Courtet, P, et al.
Publicado: (2011) -
What can we learn from selfish loci that break Mendel’s law?
por: Zanders, Sarah E.
Publicado: (2022) -
How Can We Bring Public Health in All Policies? Strategies for Healthy Societies
por: Bert, Fabrizio, et al.
Publicado: (2015) -
Bridging the academic and practice/policy gap in public health: perspectives from Scotland and Canada
por: McAteer, J, et al.
Publicado: (2019) -
What we can learn from birdsong: Mainstreaming teleworking in a post-pandemic world
por: Bojovic, D., et al.
Publicado: (2020)